COVID19 Vaccine Early Results @JennerInstitute @AstraZeneca @CEPIvaccines @UKRI_News One crucial step & v encouraging builds on incredible global research effort. To see promising results from several candidates in mths is remarkable @alexjacobharris https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S0140673620316044.pdf

We must also be prepared for some candidates to fail in the later stages & be realistic about timeframes for manufacturing & rollout. Meeting the global demand of billions of doses will require more than one vaccine

In best interests of all Govts to work collaboratively, pooling expertise & funding to access broadest pool promising vaccines. We are very encouraged by UK approach to securing access to a broad pool vaccine candidates.

Which puts UK in very strong position both in terms of access to vaccines for UK citizens & playing a leadership role in ensuring global equitable access. With limited supply globally, we must prioritise vaccine use for healthcare and essential workers, & those most vulnerable.

So that sufficient doses are available for priority populations in all countries. This is critical for the first 6-9 months of early vaccine availability, when global manufacturing capacity is unlikely to match demand. The UK is now in a strong position to make this a reality.

COVID-19 is a global challenge: no one is safe until everyone is safe. The fastest, most effective way to beat the disease and end this pandemic is by securing vaccines, tests and treatments for those who are at most risk everywhere. @alexjacobharris @wellcometrust